Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H32N2O5 |
| Molecular Weight | 500.5855 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@@]12C=CCN3CCC4=C([C@H]13)N(C5=C4C=CC=C5)C(COC(=O)C6=CC(OC)=C(OC)C(OC)=C6)=C2
InChI
InChIKey=YBXKKOCGWBHEBM-DGPALRBDSA-N
InChI=1S/C30H32N2O5/c1-5-30-12-8-13-31-14-11-22-21-9-6-7-10-23(21)32(26(22)28(30)31)20(17-30)18-37-29(33)19-15-24(34-2)27(36-4)25(16-19)35-3/h6-10,12,15-17,28H,5,11,13-14,18H2,1-4H3/t28-,30+/m1/s1
| Molecular Formula | C30H32N2O5 |
| Molecular Weight | 500.5855 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3434289
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3434289
Vinmegallate (also known as RGH-4417) was developed as a topical dermatological agent for the treatment of psoriasis. Vinmegallate is a phosphodiesterase inhibitor. However, information about the further development of this agent is not available.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:27 GMT 2025
by
admin
on
Mon Mar 31 17:58:27 GMT 2025
|
| Record UNII |
Q50MB6G17M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C744
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
||
|
NCI_THESAURUS |
C29708
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C152886
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
83482-77-3
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
6288
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
100000079133
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
DTXSID80868726
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
SUB00068MIG
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104928
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
Q50MB6G17M
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY | |||
|
3086161
Created by
admin on Mon Mar 31 17:58:27 GMT 2025 , Edited by admin on Mon Mar 31 17:58:27 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |